Oral sumatriptan for the acute treatment of probable migraine: First randomized, controlled study

Headache

Volumn 46, Issue 1, 2006, Pages 115-124

  Tepper, Stewart J ^a   Cady, Roger ^b   Dodick, David ^c   Freitag, Frederick G ^d   Hutchinson, Susan L ^e   Twomey, Colleen ^f   Kuhn, Timothy A ^f  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

^b HEADACHE CARE CENTER   (United States)

^c MAYO CLINIC   (United States)

^d DIAMOND HEADACHE CLINIC   (United States)

^e Women's Medical Group of Irvine   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Efficacy; Migrainous disorder; Probable migraine; Sumatriptan; Tolerability

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG TOLERABILITY; EVALUATION; FEMALE; HUMAN; MALE; MIGRAINE WITHOUT AURA; MULTICENTER STUDY; NAUSEA; PATIENT; POPULATION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; SEROTONIN ANTAGONISTS; SUMATRIPTAN; SURVIVAL ANALYSIS;

EID: 33645097439     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00300.x     Document Type: Article

References (20)

1. Lipton RB Stewart WF Diamond S Diamond ML Reed M Prevalence and burden of migraine in the United States: data from the American Migraine Study II Headache 2001 41 646 657
2. Hu XH Markson LE Lipton RB Stewart WF Berger ML Burden of migraine in the Unites States: disability and economic costs Arch Intern Med 1999 159 813 818
3. Stewart WF Lipton RB Celentano DD Reed ML Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors JAMA 1992 267 64 69
4. Lipton RB Diamond S Reed M Diamond ML Stewart WF Migraine diagnosis and treatment: results from the American Migraine Study II Headache 2001 41 638 645
5. Headache Classification Subcommittee of the International Headache Society The International Classification of Headache Disorders 2nd ed Cephalalgia 2004 24 suppl 1 1 160
6. Lipton R Cady R Dodick D Diamond M Demographics of migrainous headache sufferers in the United States: additional data from the American Migraine Study II [Abstract] Headache 2002 42 423
7. Tepper S Dahlof C Dowson A Newman L Kuhn TA Prevalence and demographics of migrainous headache adults in a primary care setting: data from the Landmark Study [Abstract] Cephalalgia 2003 23 622
8. Matchar DB Young WB Rosenberg JH et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks Available at Accessed April 2 2004
9. Lipton RB Scher AI Kolodner K Liberman J Steiner TJ Stewart WF Migraine in the United States: epidemiology and patterns of health care use Neurology 2002 58 885 894
10. Lipton RB Stewart WF Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999 39 suppl 2 S20 S26
11. Taylor F Hutchinson S Graff-Radford S Cady R Harris L Diagnosis and management of migraine in family practice J Fam Pract 2004 Suppl S3 S24
12. Lipton RB Stewart WF Simon D Medical consultation for migraine: results for the American Migraine Study Headache 1998 38 87 96
13. Cady RK Lipton RB Hall C Stewart WF O'Quinn S Gutterman D Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum study Headache 2000 40 783 791
14. Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain Cephalalgia 1988 8 suppl 7 1 96
15. Kosinski M Bayliss MS Bjorner JB et al. A six-item short-form survey for measuring headache impact: the HIT-6™ Qual Life Res 2003 12 963 974
16. Pascual J Vega P Diener HC Allen C Vrejens F Patel K Comparison of rizatriptan versus zolmitriptan 2.5 mg in the acute treatment of migraine Cephalalgia 2000 20 455 461
17. Diener H-C Dowson AJ Ferrari M Nappi G Tfelt-Hansen P on behalf of the Study Group Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials Cephalalgia 1999 19 699 700
18. Geraud G Olesen J Pfaffenrath V et al. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design Cephalalgia 2000 20 30 38
19. Bendtsen L Mattsson P Zwart J-A Lipton RB Placebo response in clinical randomized trials of analgesics in migraine Cephalalgia 2003 23 487 490
20. Carpay JA Linssen WHJP Koehler PJJ Arends LR Tiedink HGM Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study Headache 2003 43 395 399